Hydroxychloroquine Auxilia

Hydroxychloroquine, the active ingredient in Hydroxychloroquine Auxilia, is an antimalarial presented as an oral dosage form for oral use. It is employed in the prevention and treatment of malaria and as an immunomodulatory agent in certain rheumatic and autoimmune conditions.

GNH USA supplies Hydroxychloroquine Auxilia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxychloroquine acts on parasitic and immune pathways, making it useful in several therapeutic areas. - Malaria prophylaxis and treatment: prevents infection in travelers and treats acute malaria episodes. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Systemic lupus erythematosus: decreases disease activity and flares by modulating immune response.

Hydroxychloroquine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea or upset stomach: transient gastrointestinal discomfort. - Headache: mild to moderate intensity. - Skin rash: mild erythema or pruritus. - Visual disturbances: blurred vision or difficulty focusing.

Serious or Rare Side Effects: - Retinal toxicity: irreversible vision loss with prolonged use. - Cardiac arrhythmia: QT prolongation leading to irregular heartbeat. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Hematologic abnormalities: aplastic anemia or agranulocytosis.

Hydroxychloroquine requires careful monitoring and patient education. - Baseline eye exam: obtain ophthalmologic assessment before initiating therapy. - Cardiac monitoring: ECG recommended for patients with cardiac risk factors. - Renal or hepatic impairment: adjust dose or monitor drug levels as needed. - Pregnancy and lactation: assess risk‑benefit ratio before prescribing. - Drug interactions: review concomitant medications for QT‑prolonging agents. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Hydroxychloroquine can affect or be affected by other medicines.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption, separate dosing by at least 4 hours. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase plasma levels, risk of toxicity. - QT‑prolonging drugs (e.g., quinidine, sotalol): may cause dangerous arrhythmias.

Moderate Interactions (Monitor Closely): - Digoxin: may increase serum concentrations, monitor levels. - Insulin or oral hypoglycemics: enhanced glucose‑lowering effect, watch for hypoglycemia. - Anticoagulants (warfarin): potential increase in INR, monitor coagulation parameters.